News (262)

Combined General Meeting of Air Liquide Shareholders of April 30, 2024 BU
Air Liquide : Combined General Meeting of Air Liquide Shareholders of April 30, 2024 PU
Transcript : L'Air Liquide S.A. - Shareholder/Analyst Call
Transcript : Randstad N.V. - Shareholder/Analyst Call
Air Liquide: Combined General Meeting on April 30, 2024: Publication of the Notice of Meeting BU
Combined General Meeting on April 30, 2024: publication of the notice of Meeting PU
Siemens : Notice of Annual Shareholders’ Meeting 2024 (incl. Agenda) PU
Air Liquide : Combined Shareholders’ Meeting of May 3, 2023 PU
Air Liquide : 2023 Shareholder's guide PU
Siemens : to pay dividend of €4.25 per share; Supervisory Board becomes even more diverse PU
Siemens invites shareholders to 2023 Annual Shareholders Meeting and proposes three new Supervisory Board members AQ
Siemens : invites shareholders to 2023 Annual Shareholders’ Meeting and proposes three new Supervisory Board members PU
Safran : ITA Airways selects Safran wheels and carbon brakes for its Airbus A350 and A320neo fleets PU
Randstad N : AGM minutes 2022 PU
H1 2022 Results: Strong performance in a complex environment and confirmed resilience of the business model PU
Randstad N : AGM draft minutes 2022 PU
Air Liquide : Interactions - June 2022 PU
Air Liquide : Implementation of Air Liquide new governance structure and evolution in the Executive Committee PU
Accor : Post-AGM press release PU
Air Liquide Announces François Jackow as Chief Executive Officer as of June 1, 2022 Replacing Benoît Potier CI
Transcript : L'Air Liquide S.A. - Shareholder/Analyst Call
Accor : Information concerning the Directors proposed for appointment or renewal PU
Q1 2022: Strong sales growth and continued investment momentum PU
Safran : Canada Jetlines selects Safran wheels and carbon brakes for its A320-family fleet PU
Air Liquide : 2022 Shareholder's guide PU
Combined General Meeting on May 4, 2022: publication of the Notice of meeting PU
Air Liquide : Plan stratégique ADVANCE - Présentation (en anglais uniquement) PU
Transcript : L'Air Liquide S.A. - Analyst/Investor Day
Accor : Decisions made by the Board of Directors on February 23, 2022 PU
2021 Results: An excellent year across all performance criteria PU
Air Liquide Announces Board Changes CI
Air Liquide Announces Plan for the Succession of CEO CI
Chairman of Kawasaki, Yoshinori Kanehana, becomes a new Co-chair of the Hydrogen Council AQ
Accor : New Independent Director proposed at the 2022 Annual Shareholders’ Meeting PU
Air Liquide: Changes to share capital BU
Air Liquide : Executive Committee Evolution PU
Air Liquide is Preparing Benoît Potier’s Succession Within the Executive Management as of June 1, 2022, in Conjunction With the Implementation of a New Governance Structure BU
L'Air Liquide S.A. Announces Management Changes CI
Air Liquide and BASF Welcome Support from European Innovation Fund for Joint CCS Project BU
TotalEnergies, Air Liquide, VINCI and a Group of International Companies Launch the World’s Largest Clean Hydrogen Infrastructure Fund - Form 6-K PU
Third quarter 2021: Strong sales growth and high momentum in development projects for the energy transition and in Electronics PU
Air Liquide: Third quarter 2021: BU
Air Liquide : and Faurecia Announce a Development Agreement to Boost Hydrogen for Heavy-Duty Vehicles BU
Vinci : Air Liquide, TotalEnergies, VINCI and a group of international companies launch the world's largest clean hydrogen infrastructure fund AQ
TotalEnergies : Air Liquide, VINCI and a Group of International Companies Launch the World’s Largest Clean Hydrogen Infrastructure Fund PU
1234NextSee all

Companies (535)

T-MOBILE US 208 B $
Logo T-Mobile US

T-Mobile US, Inc. specializes in mobile telecommunication services. Sales break down by activity as follows: - mobile telecommunication services (80.5%): mobile telephone service, long-distance telephone service, data transmission, Internet access, direc ...

AT&T INC. 127 B $
Logo AT&T Inc.

AT&T Inc. is one of the leading American telecommunication operators. The activity is organized mainly around two areas: - mobile telephony; - fixed telephony and cable services: local and long-distance telephony services. The group also offers broadban ...

FERRARI N.V. 74 820 M $
Logo Ferrari N.V.

Ferrari N.V. is a holding company organized around 3 areas of activity: - manufacturing and sale of luxury sports vehicles (85.8% of net sales): 458 Italia, 488 GTB, 458 Spider, 488 Spider, F12 Berlinetta, 458 Speciale, 458 Speciale A, California T and F ...

BENO HOLDING AG 22 M $
Logo BENO Holding AG

Beno Holding AG is a Germany-based company engaged in real estate rental, development and operations business sector. The Company is focused on managing essential real estate objects economically. It offers capital-giving solutions for medium-sized, comme ...

T. ROWE PRICE GROUP INC. 26 135 M $
Logo T. Rowe Price Group Inc.

T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and internation ...

ALNYLAM PHARMACEUTICALS, INC. 19 897 M $
Logo Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...

TELSTRA GROUP LIMITED 27 038 M $
Logo Telstra Group Limited

Telstra Group Limited is an Australia-based telecommunications and technology company, offering a full range of communications services. The Company’s segments include Telstra Consumer and Small Business (TC&SB), Telstra Enterprise (TE), Networks, IT an ...

CHOW TAI FOOK JEWELLERY GROUP LIMITED 11 176 M $
Logo Chow Tai Fook Jewellery Group Limited

Chow Tai Fook Jewellery Group Limited specializes in the design, manufacture and marketing of luxury jewelry in platinum, gold and precious stones (sapphire, diamond, ruby, etc.). The group offers necklaces, earrings, rings, bracelets, pendants, etc. (Cho ...

BENO TNR, INC. 86 M $
Logo BENO TNR, Inc.

Beno TNR Inc, formerly BenoHoldings Inc, is a Korea-based company engaged in the construction business. The Company engages in the development, design, and construction of awning systems and radiant heating and cooling systems in the interior construction ...

M&T BANK CORPORATION 24 159 M $
Logo M&T Bank Corporation

M&T Bank Corporation is a banking group organized around 7 business sectors: - retail banking (29.4% of net interest income): sales of standard and specialized banking products and services (leasing, factoring, insurance, etc.); - commercial banking (22 ...

LULULEMON ATHLETICA INC. 39 114 M $
Logo lululemon athletica Inc.

lululemon athletica Inc. specializes in the design and marketing of technical sportswear for men and women. The group offers pants, t-shirts, shorts, jerseys, jackets, etc. as well as accessories (socks, shoes, rugs, bags, water bottles, etc.). Net sales ...

SAMSUNG C&T CORPORATION 15 277 M $
Logo Samsung C&T Corporation

Samsung C&T Corp is a Korea-based company principally engaged in the trading of industrial goods. The Company operates its business through six segments. The Trading segment is mainly engaged in the trading of chemicals, steel, natural materials, and livi ...

BIONTECH SE 21 342 M $
Logo BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...

KEURIG DR PEPPER INC. 47 025 M $
Logo Keurig Dr Pepper Inc.

Keurig Dr Pepper Inc. is is a leading producer of non-alcoholic beverages in North America. The group markets hot drinks, soft drinks, flavoured water, fruit juices, concentrated and syrups. Net sales break down by family of products as follows: - refres ...

T&D HOLDINGS INC. 8 695 M $
Logo T&D Holdings Inc.

T&D Holdings, Inc. is a holding company detaining shares in the life insurance companies Taiyo Life, Daido Life and T&D Financial Life. ...

LEGEND BIOTECH CORPORATION 7 565 M $
Logo Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...

TRUWORTHS LIMITED - $
Logo Truworths Limited

Truworths Limited specializes in the design, manufacturing and marketing of clothes and accessories for men and women. Net sales break down by activity as follows: - retail distribution of clothes and accessories (98.6%): Nine West, Guess, Ka'yanda, Bert ...

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 5 403 M $
Logo GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicine ...

HLA GROUP CORP., LTD. 6 109 M $
Logo Hla Group Corp., Ltd.

HLA GROUP CORP LTD, formerly Hla Corp Ltd, is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of b ...

BAIC BLUEPARK NEW ENERGY TECHNOLOGY CO.,LTD. 5 707 M $
Logo BAIC BluePark New Energy Technology Co.,Ltd.

BAIC BluePark New Energy Technology Co Ltd is a China-based company mainly engaged in the research, development, design, manufacturing, sales and service of pure electric passenger vehicles. The Company mainly owns the two brands of Jihu and BEIJING. Its ...

J&T GLOBAL EXPRESS LIMITED 9 398 M $
Logo J&T Global Express Limited

J&T Global Express Ltd is a China-based company principally engaged in global logistics services. The Company's businesses include express delivery services, cross-border logistics services, sales accessories and other services. The express delivery servi ...

VALMONT INDUSTRIES, INC. 5 492 M $
Logo Valmont Industries, Inc.

Valmont Industries, Inc. is a manufacturer of products and services for infrastructure and agricultural markets. The Company operates through two segments: Infrastructure and Agriculture. The Infrastructure segment consists of the manufacture and distribu ...

L&T TECHNOLOGY SERVICES LIMITED 6 139 M $
Logo L&T Technology Services Limited

L&T Technology Services Limited is an India-based engineering research and development (ER&D) services provider. The Company offers consultancy, design, development and testing services across the product and process development life cycle. The Company op ...

LI NING COMPANY LIMITED 5 973 M $
Logo Li Ning Company Limited

Li Ning Company Limited is specialized in designing, manufacturing and marketing clothing, shoes and sports equipment. The group offers products under its own brand (LI-NING) and licensed brands (Double Happiness, AIGLE, Danskin, Kason and Lotto). Net sal ...

FIVE BELOW, INC. 6 295 M $
Logo Five Below, Inc.

Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...

MEDIGENE AG 40 M $
Logo Medigene AG

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-bas ...

GILDAN ACTIVEWEAR INC. 6 373 M $
Logo Gildan Activewear Inc.

Gildan Activewear Inc. is a vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products. Its primary product categories include activewear tops and bottoms (activewear), socks (hosiery), and underwea ...

THAI SUGAR TERMINAL 155 M $
Logo Thai Sugar Terminal

TSTE Public Company Limited, formerly Thai Sugar Terminal Public Company Limited, is a Thailand-based company, which is a provider of logistics services. It operates businesses relating to transfer and transportation services for sugar and certain agricul ...

AUTOLUS THERAPEUTICS PLC 1 147 M $
Logo Autolus Therapeutics plc

Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using ...

CUROCELL INC. 308 M $
Logo Curocell Inc.

Curocell Inc is a Korea-based company principally engaged in the manufacture, research and development (R&D) of drugs. The Company is also engaged in the development of novel chimeric antigen receptor (CAR)-T therapy technologies targeting novel cancer an ...

TC BIOPHARM (HOLDINGS) PLC 5 M $
Logo TC Biopharm (Holdings) Plc

TC BioPharm Limited is a clinical-stage cell therapy company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infecti ...

CERO THERAPEUTICS HOLDINGS, INC. 5 M $
Logo CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable cha ...

ATARA BIOTHERAPEUTICS, INC. 51 M $
Logo Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with s ...

LUX INDUSTRIES LIMITED 527 M $
Logo Lux Industries Limited

Lux Industries Limited is an India-based company, which is primarily engaged in the business of manufacturing knitted garments. The Company's products include men's, women's and kids' innerwear, winterwear, socks and slacks for women in varied colors and ...

CYTOMED THERAPEUTICS LIMITED 23 M $
Logo CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company. The Company is focused on harnessing its licensed proprietary technologies to create cell-based immunotherapies for the treatment of human cancers. The development of its technologi ...

ADAPTIMMUNE THERAPEUTICS PLC 239 M $
Logo Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy ca ...

TSCAN THERAPEUTICS, INC. 393 M $
Logo TScan Therapeutics, Inc.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company’s lead TCR-T therapy c ...

MUSTANG BIO, INC. 21 M $
Logo Mustang Bio, Inc.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to adva ...

KALTURA, INC. 191 M $
Logo Kaltura, Inc.

Kaltura, Inc. is a video technology provider. The Company's segments include Enterprise, Education, and Technology (EE&T) and Media and Telecom (M&T). The EE&T segment represents products related to industry solutions for education customers, and media se ...

MAGYAR TELEKOM TÁVKÖZLÉSI NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG 2 585 M $
Logo Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság

Magyar Telekom Tavkozlesi Nyrt is engaged in providing fixed line and mobile telecommunication services for public and business customers. The Company's segments include Telekom Hungary, T-Systems, Macedonia and Montenegro. Its Telekom Hungary segment ope ...

GRACELL BIOTECHNOLOGIES INC. 991 M $
Logo Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric ant ...

T&R BIOFAB CO., LTD. 98 M $
Logo T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production ...

SNT ENERGY CO., LTD. 142 M $
Logo SNT Energy Co., Ltd.

SNTEnergy Co Ltd, formerly S&T Corp, is a Korea-based company engaged in the manufacture and sale of heat exchangers. The Company manufactures heat exchangers, which are used for petrochemical plants, oil refining plants, gas plants and others; heat recov ...

ANIXA BIOSCIENCES, INC. 83 M $
Logo Anixa Biosciences, Inc.

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs in ...

IN8BIO, INC. 44 M $
Logo IN8bio, Inc.

IN8bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T c ...

ADICET BIO, INC. 108 M $
Logo Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead produc ...

NCR ATLEOS CORPORATION 2 080 M $
Logo NCR Atleos Corporation

NCR Atleos Corporation is a financial technology company providing self-directed banking solutions to a global customer base, including financial institutions, merchants, manufacturers, retailers and consumers. The Company's solutions enable the accelerat ...

SNT HOLDINGS CO., LTD. 225 M $
Logo SNT Holdings Co., Ltd.

SNT Holdings Co Ltd, formerly S&T Holdings Co Ltd, is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company operates in four business divisions: automobile parts division, which manufactures axl ...

RECTIFIER TECHNOLOGIES LIMITED 7 M $
Logo Rectifier Technologies Limited

Rectifier Technologies Limited is an Australia-based company, which designs and manufactures high-efficiency power rectifiers and produces electronic and specialized magnetic components. The Company's segments include Electronic Components, Industrial Pow ...

GUOBO ELECTRONICS CO., LTD. 4 046 M $
Logo Guobo Electronics Co., Ltd.

Guobo Electronics Co Ltd is a China-based company mainly engaged in the research and development, production and sales of active phased array transmitter and receiver (T/R) components and radio frequency integrated circuits related products. The Company's ...

IMUGENE LIMITED 280 M $
Logo Imugene Limited

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to ha ...

CARGO THERAPEUTICS, INC. 627 M $
Logo CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chime ...

ALLOGENE THERAPEUTICS, INC. 480 M $
Logo Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core p ...

MARKER THERAPEUTICS, INC. 43 M $
Logo Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It h ...

CONNECT BIOPHARMA HOLDINGS LIMITED 91 M $
Logo Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company focused on improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research. It is building ...

INTERNATIONAL KNITWEAR LIMITED 502 755 $
Logo International Knitwear Limited

International Knitwear Limited is a Pakistan-based company that is engaged in creating, developing and manufacturing knitted and woven apparel products. The Company is also engaged in the export of garments. Its product categories include men's wear, ladi ...

CELYAD ONCOLOGY SA 13 M $
Logo Celyad Oncology SA

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprie ...

KYVERNA THERAPEUTICS, INC. 340 M $
Logo Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company. The Company is focused on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead program, KYV-101, is an autologous CD19 CAR ...

CABALETTA BIO, INC. 452 M $
Logo Cabaletta Bio, Inc.

Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administra ...

MAFIA TRENDS LIMITED 822 111 $
Logo Mafia Trends Limited

Mafia Trends Limited is an India-based company that is engaged in the business of trading of apparels and readymade garments. The Company is involved in the business of marketing and selling of men's fashion, which includes apparels such as jeans, t-shirt ...

M&T 1997, 17 M $
Logo M&T 1997,

M&T 1997 as is a Czech Republic-based company primarily engaged in appliances, tools and housewares business industry. The Company is a producer and designer of various sizes and shapes, brass handles, door fittings and window fittings under the M & T bra ...

SANU GOLD CORP. 7 M $
Logo Sanu Gold Corp.

Sanu Gold Corp. is a Canada-based junior mineral exploration-stage company. The Company is exploring three gold exploration permits. Its projects include Bantabaye, Daina and Diguifara. The Bantabaye is located within the Siguiri Basin, approximately 70 k ...

GARMENT MANTRA LIFESTYLE LIMITED 8 M $
Logo Garment Mantra Lifestyle Limited

Garment Mantra Lifestyle Limited is an India-based company engaged in the business of manufacturing, selling and distribution of fabrics, hosiery garments and providing related services. The Company offer a range of fabric types and can apply coatings or ...

THAI ENERGY STORAGE TECHNOLOGY 113 M $
Logo Thai Energy Storage Technology

Thai Energy Storage Technology PCL is a Thailand-based company, which is engaged in the manufacturing and distribution of batteries. The Company’s product categories include automotive battery, traction battery, EB battery, lighting battery, and golf ca ...

VIRAX BIOLABS GROUP LIMITED 4 M $
Logo Virax Biolabs Group Limited

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling ...

IMMUNOTECH BIOPHARM LTD 206 M $
Logo Immunotech Biopharm Ltd

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR ...

PDS BIOTECHNOLOGY CORPORATION 98 M $
Logo PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused ant ...

CORVUS PHARMACEUTICALS, INC. 121 M $
Logo Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitini ...

T&G GLOBAL LIMITED 127 M $
Logo T&G Global Limited

T&G Global Limited is a grower, distributor, marketer and exporter of fresh produce, which includes apples, berries, citrus (lemons, mandarins and navel oranges) and tomatoes. The Company's segments include Apples, International Trading, T&G Fresh, Ventur ...

2SEVENTY BIO, INC. 210 M $
Logo 2seventy bio, Inc.

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). ...

PRESCIENT THERAPEUTICS LIMITED 22 M $
Logo Prescient Therapeutics Limited

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, ...

CYTOMX THERAPEUTICS, INC. 107 M $
Logo CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and be ...

SANA BIOTECHNOLOGY, INC. 1 329 M $
Logo Sana Biotechnology, Inc.

Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, incl ...

ALLOVIR, INC. 83 M $
Logo AlloVir, Inc.

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms l ...

KINETA, INC. 7 M $
Logo Kineta, Inc.

Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...

CARSGEN THERAPEUTICS HOLDINGS LIMITED 433 M $
Logo CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Company’s therapies are applied in the trea ...

VIGENCELL INC. 54 M $
Logo ViGenCell Inc.

ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In additi ...

CARTESIAN THERAPEUTICS, INC. 415 M $
Logo Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platfo ...

NEXIMMUNE, INC. 4 M $
Logo NexImmune, Inc.

NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates inc ...

IMMUTEP LIMITED 395 M $
Logo Immutep Limited

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or ...

TRIMURTHI LIMITED 2 M $
Logo Trimurthi Limited

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Servic ...

ELICERA THERAPEUTICS AB 4 M $
Logo Elicera Therapeutics AB

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The Company is developing next-generation cell and gene therapies for immune-based treatment of cancer. The company is developing four drug candidates, two of which are in t ...

LYELL IMMUNOPHARMA, INC. 553 M $
Logo Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. The Company is engaged in enrolling a Phase I clinical trial evaluating a ROR1-targeted CAR T-cell the ...

INSTIL BIO, INC. 65 M $
Logo Instil Bio, Inc.

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first ...

CHIMERIC THERAPEUTICS LIMITED 10 M $
Logo Chimeric Therapeutics Limited

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. I ...

CELL SOURCE, INC. 32 815 $
Logo Cell Source, Inc.

Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management ...

ALX ONCOLOGY HOLDINGS INC. 384 M $
Logo ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate ...

SHINE-ON BIOMEDICAL CO.,LTD. 101 M $
Logo Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody ...

FOXTRON VEHICLE TECHNOLOGIES CO., LTD. 2 417 M $
Logo Foxtron Vehicle Technologies Co., Ltd.

Foxtron Vehicle Technologies Co Ltd is a Taiwan-based company mainly engaged in the research and development of electric vehicle technology, the manufacture, management and sale of vehicle and component. The company's main products include an open platfor ...

CUE BIOPHARMA, INC. 65 M $
Logo Cue Biopharma, Inc.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and b ...

CARIBOU BIOSCIENCES, INC. 158 M $
Logo Caribou Biosciences, Inc.

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its gen ...

EUTILEX.CO.,LTD 53 M $
Logo Eutilex.Co.,Ltd

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies. ...

JANUX THERAPEUTICS, INC. 2 078 M $
Logo Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) ...

TEVOGEN BIO HOLDINGS INC. 145 M $
Logo Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious ...

TELETOUCH COMMUNICATIONS, INC. 49 $
Logo Teletouch Communications, Inc.

Teletouch Communications, Inc. (Teletouch) offers a suite of telecommunications products and services, including cellular, two-way radio, global positioning system (GPS)-telemetry, wireless messaging and public safety equipment. The Company is an authoriz ...

POLTREG S.A. 56 M $
Logo Poltreg S.A.

Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm ...

ULTIMOVACS ASA 28 M $
Logo Ultimovacs ASA

Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing ...

NOILE-IMMUNE BIOTECH INC. 50 M $
Logo Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc is a Japan-based company mainly engaged in the development of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors using proprietary technology. The Cancer Immunotherapy Drug Discovery Business segment develops variou ...

T SCIENTIFIC CO.,LTD. 54 M $
Logo T Scientific Co.,Ltd.

T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services. ...

NEOIMMUNETECH, INC. 22 M $
Logo NeoImmuneTech, Inc.

NeoImmuneTech, Inc. is a clinical-stage T cell-focused biopharmaceutical company. The Company is engaged in the discovery and development of immuno-therapeutics. Its lead asset includes NT-I7 (efineptakin alfa), which is a T Cell Amplifier. NT-I7 is a hum ...


1234Next

Insiders

Benoît Potier
Benoît Potier

Benoît Potier is currently the Chief Executive Officer of Air Liquide Tunisie SA and the Chairman & Co-Chief Executive Officer of Air Liquide Italia SpA.
He is also the Chairman of Air Liquide SA, Chairman of Vitalaire Italia SpA, and Director of École Centrale Paris.
In addition, he serves as a Director of Fondation d'entreprise Air Liquide, Member-Supervisory Board of Siemens AG, and Member-France Board of INSEAD.
He is also a Member of the European Round Table of Industrialists, Asia Business Council, International Advisory Panel, Observatoire Des Actionnaires D’Avenir, and The Hydrogen Council.
Formerly, Mr. Potier held the positions of Chairman, President & Chief Executive Officer of Air Liquide International Corp.
and Chairman & Chief Executive Officer of Air Liquide International SA. He was also Chairman & Chief Executive Officer of Air Liquide Advanced Technologies SA and a Non-Independent Director of Danone SA. He served as a Director of various organizations including Association Française des Entreprises Privées, American Air Liquide Holdings, Inc., Association Nationale des Sociétés par Actions, Le Cercle de l'Industrie, Etudes et Realisations de Travaux SAS, Fabrique de Lindustrie, CentraleSupélec Exed SA, Air Liquide Foundation, The Hydrogen Co. SA, and Compagnie Générale des Établissements Michelin SCA.
He is also a Member of the Trilateral Commission European Group.
Mr. Potier obtained his undergraduate degree from École Centrale Paris in 1979.






Picture Franck Potier
Franck Potier

Franck Potier worked as Vice President-Sales & Marketing at Nexeya SA from 2013 to 2017.
He holds an MBA from INSEAD, which he received in 1999, and an undergraduate degree from École supérieure d'électricité, which he received in 1991.





Picture Jean-Luc Potier
Jean-Luc Potier

Jean-Luc Potier is currently the President of Forafrance SAS.
Previously, he worked as the Development Director at Société Foncière Lyonnaise SA from 1997 to 2012.
He also worked as a Director at John Cockerill SA.







Picture Olivier Potier
Olivier Potier

Olivier Potier has a current job as an Economist at Crédit Agricole SA (Research Firm) since 2020.



Picture Pierre Potier
Pierre Potier

Pierre Potier founded Domain Therapeutics SA in 2008.




Picture Valérie Potier
Valérie Potier

Valérie Potier is currently a Director at Hamon & Cie (International) SA since 2015.
Previously, she worked as a Manager at Ernst & Young Accountants CVBA.
She completed her undergraduate degree at HEC-ULG Management School.


Picture Barry Potier
Barry Potier

Barry Potier is the founder of Visage, Inc. (California).
He held the title of Chief Operating & Financial Officer at the company.




Picture Lionel Potier
Lionel Potier

Lionel Potier is a Senior Banking Economist at Crédit Agricole SA (Research Firm) since 2020.






Picture Olivier Potier
Olivier Potier

Olivier Potier is the Chairman and Chief Executive Officer of Christian Potier SA, which he founded in 1985.


Picture Julien Potier
Julien Potier

Julien Potier is associated with three different firms.
He is currently the Director of Le Châtelard 1802 SA and a Member-Supervisory Board of Nextstage Evergreen SCA (France).
He has previously worked as an Investment Manager at NextStage AM SAS from 2011 onwards.


Picture Philippe Potier
Philippe Potier

Philippe Potier currently works at Société Coopérative Agricole et Agro-alimentaire AGRIAL SCA, as Secretary & Director from 2012 and Eclor Entreprises SASU, as Member-Supervisory Board.






Picture Manuel Potier
Manuel Potier

Manuel Potier has a current job as an Investment Director at Sofilaro SAS.










Picture Dominique Potier Bassoulet
Dominique Potier Bassoulet

Ms. Dominique Potier Bassoulet is an Independent Director at Foncière Inea, a Head-Key Clients at BNP Paribas Groupe (France), a Chairman at Arabelle Investissements and a Chief Executive Officer at Paracas SAS.
She is on the Board of Directors at Foncière Inea, Patrimoine Partenaires and Valtitres Sicav.
Ms. Potier Bassoulet was previously employed as a Co-Manager by Figoli SARL.
She also served on the board at Portzamparc Société de Bourse SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris.



No results for this search